HealthSouth Corp. (HLS) Receives $46.13 Average PT from Analysts
HealthSouth Corp. (NYSE:HLS) has been given a consensus recommendation of “Buy” by the twelve analysts that are currently covering the stock. One analyst has rated the stock with a sell recommendation, three have given a hold recommendation and seven have assigned a buy recommendation to the company. The average twelve-month target price among brokerages that have covered the stock in the last year is $46.13.
Several research analysts have recently weighed in on HLS shares. Barclays PLC cut HealthSouth Corp. from an “equal weight” rating to an “underweight” rating and reduced their price objective for the stock from $45.00 to $42.00 in a research report on Monday, June 27th. They noted that the move was a valuation call. Wells Fargo & Co. reaffirmed a “buy” rating on shares of HealthSouth Corp. in a research report on Sunday, September 11th. Zacks Investment Research raised HealthSouth Corp. from a “hold” rating to a “buy” rating and set a $47.00 price objective for the company in a research report on Monday, August 1st. SunTrust Banks Inc. set a $54.00 price objective on HealthSouth Corp. and gave the stock a “buy” rating in a research report on Monday, August 1st. Finally, JMP Securities reaffirmed a “buy” rating on shares of HealthSouth Corp. in a research report on Sunday, September 4th.
Shares of HealthSouth Corp. (NYSE:HLS) opened at 40.66 on Tuesday. HealthSouth Corp. has a 12-month low of $30.26 and a 12-month high of $43.38. The firm has a 50-day moving average price of $40.65 and a 200-day moving average price of $39.97. The firm has a market cap of $3.65 billion, a price-to-earnings ratio of 17.85 and a beta of 1.02.
HealthSouth Corp. (NYSE:HLS) last posted its earnings results on Thursday, July 28th. The company reported $0.69 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.60 by $0.09. HealthSouth Corp. had a return on equity of 28.99% and a net margin of 6.26%. The firm earned $920.70 million during the quarter, compared to analysts’ expectations of $906.67 million. During the same period in the previous year, the firm earned $0.47 earnings per share. The company’s revenue was up 20.4% on a year-over-year basis. Equities research analysts anticipate that HealthSouth Corp. will post $2.52 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, October 17th. Shareholders of record on Monday, October 3rd will be paid a $0.24 dividend. This is a positive change from HealthSouth Corp.’s previous quarterly dividend of $0.23. The ex-dividend date is Thursday, September 29th. This represents a $0.96 annualized dividend and a yield of 2.36%. HealthSouth Corp.’s dividend payout ratio is currently 42.29%.
In other HealthSouth Corp. news, COO Mark J. Tarr sold 20,000 shares of the company’s stock in a transaction that occurred on Tuesday, August 2nd. The stock was sold at an average price of $41.85, for a total value of $837,000.00. Following the sale, the chief operating officer now owns 252,519 shares in the company, valued at $10,567,920.15. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 5.00% of the stock is owned by company insiders.
A number of hedge funds have recently added to or reduced their stakes in the stock. William Blair Investment Management LLC raised its stake in HealthSouth Corp. by 37.7% in the second quarter. William Blair Investment Management LLC now owns 3,061,817 shares of the company’s stock valued at $118,860,000 after buying an additional 837,747 shares in the last quarter. Bank of Montreal Can acquired a new stake in HealthSouth Corp. during the second quarter valued at about $22,389,000. Allianz Asset Management AG raised its stake in HealthSouth Corp. by 382.0% in the second quarter. Allianz Asset Management AG now owns 716,684 shares of the company’s stock valued at $27,822,000 after buying an additional 567,979 shares in the last quarter. Renaissance Technologies LLC raised its stake in HealthSouth Corp. by 321.1% in the first quarter. Renaissance Technologies LLC now owns 638,400 shares of the company’s stock valued at $24,023,000 after buying an additional 486,800 shares in the last quarter. Finally, Cumberland Partners Ltd raised its stake in HealthSouth Corp. by 178.5% in the second quarter. Cumberland Partners Ltd now owns 559,025 shares of the company’s stock valued at $21,702,000 after buying an additional 358,325 shares in the last quarter. Hedge funds and other institutional investors own 94.94% of the company’s stock.
About HealthSouth Corp.
HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in over 30 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company’s segments include inpatient rehabilitation, and home health and hospice.
Receive News & Ratings for HealthSouth Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corp. and related companies with MarketBeat.com's FREE daily email newsletter.